期刊文献+

P33ING1、p53基因在膀胱移行细胞癌中的表达及其意义 被引量:1

Expression of P33ING1,p53 in Bladder Transitional Cell Carcinoma and its Significance
暂未订购
导出
摘要 目的探讨抑癌基因P33ING1在膀胱移行细胞癌中的表达及其与p53蛋白表达的相关性。方法采用免疫组化S-P法,检测83例膀胱移行细胞癌及11例正常膀胱黏膜组织中P33ING1、p53的表达。结果83例膀胱移行细胞癌组织中P33ING1蛋白阳性表达率为59.03%,而正常膀胱黏膜组织中P33ING1蛋白阳性表达率为90.90%。P33ING1蛋白表达与膀胱移行细胞癌的WHO肿瘤分级相关。根据Spearman相关分析表明P33ING1蛋白表达与p53蛋白表达呈正相关关系(P<0.05)。结论P33ING1基因可能在膀胱移行细胞癌的发生、发展过程中起重要作用,P33ING1与p53基因具有协同作用,同时检测p53和P33ING1表达水平,对膀胱癌的诊断、治疗和预后判断可能具有积极意义。 Objective To investigate the expression of tumor suppressor gene p33ING1 in bladder transitional cell carcinoma(BTCC) and its relationship with p53 protein expression. Methods The expression of P33ING1 and p53 was detected byimmunohistochemical SP method in the tissues from 83 cases with BTCC and 11 normal bladder mucosa tissues. Results The expression of P33ING1 protein in the BTCC and normal bladder mucosa tissues was 59.03% and 90.90% , respectively. P33ING1 protein expression was related to the WHO tumor grade in bladder transitional cell carcinoma. P33ING1 protein and p53 protein expression was positively correlated by Spearman correlation analysis ( P 〈 0.05 ). Conclusion P33INGI gene may be involved in the oneogenesis and development of bladder transitional cell carcinoma. The combined detection of P33ING1 and p53 might be helpful in the diagnosis, treatment and prognosis of patients with bladder cancer.
出处 《实用癌症杂志》 2010年第2期140-142,共3页 The Practical Journal of Cancer
基金 云南省教委资助项目(07C40350)
关键词 P33ING1基因 P53基因 膀胱移行细胞癌 P33 ING1 gene p53 gene Bladder transitional cell carcinoma ( BTCC )
  • 相关文献

参考文献9

  • 1Garkavtsev I, Kazarov A, Gudkov A, et al. Suppression of the novel growth inhibitor p33/INGI promotes neoplastic transformation[J].Nature Genet, 1996,14 (4) :415.
  • 2Ma D, Lawless D, Riabowol. Suppression of the novel growth inhibitor p33 INGI promotes neoplastic transformation (correction)[J].Nature Genet, 1999,23 ( 3 ) : 273.
  • 3Garkavtsev I, Riabowol K. Extension of the replieative life span of human diploid fibroblasts by inhibition of P33 INGI candidate tumor suppressor [J]. Mol Cell Bid, 1997,17 (4) : 2014.
  • 4曾凡军,周媛媛.p33ING1与非小细胞肺癌相关性的研究进展[J].山东医药,2009,49(3):113-114. 被引量:3
  • 5Helbing CC, Veillette C, Riabowol K, et al. A novel candidate tumor suppression P33/INGI is involved in the regulation of apoptosis [J].Cancer Res, 1997,57 (7) : 1255.
  • 6Nouman GS, Angus B, Lunec J, et al. Comparative assessment of expression of the inhibitor of growth 1 gene (INGI) in norm al and neoplastic tissues [J]. Hybridoma, 2002,21 (1):1.
  • 7Tokunage E, M aehara Y, Oki E, et al. Diminished exp ression of ING1 mRNA and the correlation with p53 expression in breast cancers[J]. Cancer Lett,2000,152 ( 1 ) : 15222.
  • 8祝峙,朱明华,倪灿荣.原发性肝细胞癌癌组织中p33^(ING1b)与p53基因的表达[J].中华医学杂志,2002,82(19):1332-1336. 被引量:20
  • 9李启忠,王向阳.P33^ING1b在膀胱移行细胞癌中的表达及其意义[J].国际外科学杂志,2007,34(6):376-378. 被引量:2

二级参考文献29

共引文献19

同被引文献11

  • 1陈扬华,黄金宁,周雄,张子恒,梁丽棠.上皮钙黏附素和树突细胞在膀胱癌中的表达及其意义[J].中华实验外科杂志,2006,23(7):858-859. 被引量:10
  • 2杨新宇,李峻,夏同礼,何群,李文,苏晋伟,王静华,那彦群.P53蛋白、网膜母细胞瘤基因蛋白及增殖细胞核抗原的异常表达与尿路上皮癌复发的预后研究[J].中华外科杂志,2007,45(2):131-132. 被引量:3
  • 3Donato R. S-100 : a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles [J]. Int J Biochem Cell Biol, 2001, 33(7): 637-638.
  • 4Becker Y, Anticancer role of dendritic cells in human an experimental cancer[J]. Anticancer Res, 1992, 12 (2) : 511-514.
  • 5Engleman E G. Dendritic cell-based cancer immunotherapy[J]. SerminOncol, 2003, 30(3): 23-29.
  • 6Cai X Y, Gao Q, Qiu S J, et al. Dendritic cell infiltration and prognosis of human hepatocellular carcinoma[J]. Cancer Res Clin Oncol, 2006, 19(6):1-9.
  • 7Anderson D M, Maraskovshy E, Billingslev W L,et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function[J]. Nature, 1997, 390(6656) :175-179.
  • 8Banchereau J, Stainman R M. Dendritic cells and the control of immunity[J]. Nature,1998, 392(3): 245-252.
  • 9Molinie V, Longchampt E, Ouazana D, et al. New markers in urinary bladder caneer[J]. Am J Pathol, 2003, 23(4):306-331.
  • 10周辉良,吕夷松,许宁,唐松喜,薛学义,毛厚平,曹林升,罗义麒.WHO2004分级法预测膀胱非肌层浸润性尿路上皮癌复发的价值[J].现代泌尿生殖肿瘤杂志,2009,1(1):22-24. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部